Aqueous Biomarker Levels in Diabetic Retinopathy and Diabetic Macular Edema
NCT05333055 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 107
Last updated 2025-01-24
Summary
The DRAGONS study is a non-interventional, prospective study that will
1. characterize disease state biomarker (including cytokines, KKS metabolites, and cell adhesion molecules) levels from aqueous humor of subjects with various stages of diabetic retinopathy (DR) and diabetic macular edema (DME) as well as other retinal pathologies, and
2. correlate a broad array of aqueous humor disease state biomarkers with DR severity, DME anti-vascular endothelial growth factor (VEGF) responsiveness, and other retinal pathologies.
Conditions
- Diabetic Retinopathy
- Diabetic Macular Edema
- Other Retinal Disorders
Sponsors & Collaborators
-
Greater Houston Retina Research
lead OTHER
Principal Investigators
-
Charles C. Wykoff, MD, PhD · Greater Houston Retina Research
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-02-10
- Primary Completion
- 2024-05-15
- Completion
- 2024-05-15
Countries
- United States
Study Locations
More Related Trials
-
Systemic and Local Inflammatory Biomarkers in the Treatment of Refractory Diabetic Macular Edema
NCT06179030 ·Status: COMPLETED
-
Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales
NCT06914778 ·Status: RECRUITING
-
Non-Responsive Diabetic Macular Edema and Spironolactone
NCT04853355 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study of Avoralstat In Participants With Diabetic Macular Edema
NCT07228559 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase 2a Study to Evaluate the Safety, Tolerability, and Efficacy of SNP318 in DME Patients
NCT07199777 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
NCT02302079 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers of Diabetic Retinopathy Progression
NCT01607190 ·Status: COMPLETED
-
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
NCT05802329 ·Status: RECRUITING ·Phase: PHASE1
-
A Single Ascending Dose Cohort Study of AG-73305 in DME Patients
NCT05301751 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema
NCT01702441 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)
NCT02103283 ·Status: COMPLETED ·Phase: PHASE1
-
Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy
NCT01175486 ·Status: UNKNOWN ·Phase: PHASE4
-
Multimodal Image Study of Retinal Inflammation Markers After Corticoid and Antiangiogenic Treatment in Pacients With Diabetic Macular Edema
NCT03583242 ·Status: UNKNOWN
-
Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide
NCT02221453 ·Status: COMPLETED ·Phase: PHASE2
-
Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease
NCT04429503 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy
NCT02307110 ·Status: COMPLETED ·Phase: NA
-
Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography
NCT01790945 ·Status: UNKNOWN
-
Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy
NCT04692688 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Restoration in Vitreous Hemorrhage Patients With DME After or Not Removing Inner Limiting Membrane
NCT05529589 ·Status: UNKNOWN
-
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema
NCT06116916 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema
NCT02441907 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema
NCT04292912 ·Status: TERMINATED ·Phase: PHASE1
-
Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema
NCT00320814 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema
NCT04527107 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Combination Steroid and Anti-VEGF for Persistent DME
NCT01945866 ·Status: COMPLETED ·Phase: PHASE2